Why 2023 is shaping up as a critical year for drug makers (Hint: It has something to do with cash)

See our list of first-quarter Bay Area biotech clinical milestones — and help us add to it.

Previous State's changes 340B pharmacy program could lead to losses of $30M and 300 jobs
Next New restaurants, including first Chick-fil-A, coming to O'Hare